Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
FG-3246 Phase II trial advances with 36% PSA50 response in monotherapy.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Dow closes down more than 700 points over bond market, national debt fears
The Dow closed down over 700 points on Thursday amid rising national debt and fears over bond market volatility. Jessica Inskip, director of investor research at Stockbrokers.com, joins CBS News to…
Newsmax (NMAX) Q2 2026 Earnings Call Transcript
First profitable quarter as affiliate fees and licensing surge.
Jefferson Capital (JCAP) Q2 2026 Earnings Call Transcript
Collections surged 18% as company enters Mexico and expands into auto finance.